Navigation Links
PreMD Reports Fiscal 2007 Results
Date:3/28/2008

---------------------------------------------------------------------

-------------------------------------------------------------------------

PreMD Inc.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Canadian dollars)

Years ended December 31

2007 2006 2005

$ $ $

-------------------------------------------------------------------------

OPERATING ACTIVITIES

Net loss and comprehensive

loss for the year (6,315,812) (5,948,971) (4,989,705)

Add (deduct) items not

involving cash

Amortization 165,753 319,205 256,260

Stock-based compensation

costs included in

Research and development

expense 193,527 156,920 147,085

General and administration

expense 400,821 383,767 421,812

Loss (gain) on sale of capital

assets 139,669 (1,743) -

Imputed interest on

convertible debentures 1,002,394 819,609 255,529

Mark-to-market adjustment

on derivative 18,000 - -

Interest on convertible

debentures paid in

common shares 543,312 281,462 -

Loss (gain) on foreign exchange (1,288,160) 97,748 (35,734)

Net change in non-cash working

capital balances related to

operations (1,011,237) 1,422,730 (1,061,397)

Increase (decrease) in deferred

revenue 480,060 (2,609,315) (301,885)

------------------------------
'/>"/>

SOURCE PreMD Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. PreMD Provides Update on 510(k) Application for PREVU(x) POC
2. PreMD Inc. Provides Corporate Update
3. PreMD Announces Valuable Data on PREVU(x) LT Life Insurance Product
4. PreMD Announces FDA Decision on POC Skin Cholesterol Test
5. PreMD Initiates FDA Review Process and Provides Corporate Update
6. PreMD Inc. Announces Debenture Financing
7. PreMD Inc. Signs Agreement with Cosmetics Conglomerate
8. PreMD Inc. Completes Debenture Financing
9. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
10. Haemacure Reports Third Quarter 2007 Results
11. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...UCCESS, N.Y., July 25 /PRNewswire-USNewswire/ -- A...ief Quality Officer and Vice President,of Strategi...alth Fund, a,national foundation committed to impr...ected the foundation,s Program on Health Care Qual...ww.newscom.com/cgi-bin/prnh/20080725/DC28791LOGO ...
(Date:7/25/2008)...ty of Phoenix employees at 62 campuses, 43 affilia...lp feed nation,s hungry, PHOENIX, July 25 /PRNews...n,s hungry as employees at University of Phoenix, ...artments and four subsidiaries collected,enough no...provide more,than 68,000 meals. The staggering tot...
(Date:7/25/2008)...mmune response after antiretroviral therapy may be... 25 (HealthDay News) -- A new study challenges the... impairs the immune system,s ability to restore it...tive antiretroviral therapy (HAART). , From 50 ...re also infected with HCV. Intravenous drug use is...
(Date:7/25/2008)... GA July 24, 2008 Being overweight or obese is n... but is also a public health issue that impacts ot... Health Services Research reveals that the extra ...eople could place a significant financial burden o...f dollars across the entire current Medicare popul...
Breaking Medicine News(10 mins):Health News:IPRO Welcomes Back Anthony Shih as Chief Quality Officer, Strategic Planning Lead 2Health News:Hunger Is Happening National Food Drive a Huge Success -- Donations Will Serve 68,000 Meals 2Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2
...de, a controversial non-steroidal anti-inflammator...ain the health ministry admitted that drug formula... and not evaluated for effectiveness are prescribe... Jurist, a group of lawyers in New Delhi had filed...
...had launched a new research project to prevent the...from attacking the people. The research will aim t...flect it from biting the human populations. Malari...nd is spread by the mosquitoes that bite an infect...
...f an adverse intrauterine environment could be an ...ular disease, according to the study published in ...gs was obtained by studying 13830 individuals born...ata pertaining to the primary causes of death betw...
...anced/metastatic breast cancer in postmenopausal w...sts as a second line of treatment for infertility ...ozole was used not on an experimental basis, but a...ovulation. However some feel that without clinica...
Other Medicine News:Health News:Justifying the use of letrozole for inducing ovulation 2
(Date:7/24/2008)... WASHINGTON, July 24 /PRNewswire-USNewswire/ --...t" do not tell the whole story. The small scale,p...d online in Human,Reproduction, is based on recoll... containing soyfoods. "This study is confounded by...ewed with a great deal of,caution," warned Dr. Tam...
(Date:7/24/2008)... SOPHIA ANTIPOLIS, France, July 24 /PRNewswire-...ay announced the top-line results from the 52-week...llowing the completion of,the 301 phase 3 study fo...safety findings and efficacy was maintained for th...he patients, global assessment scale. In,addition,...
(Date:7/23/2008)... WASHINGTON, July 23 /PRNewswire-USNewswire/ --... of Justice:, Chairman Conyers, Ranking Member Sm...he opportunity to testify today., Since I appeare...ave,become even better acquainted with the talente...tment and with the work they do, and I have come t...
(Date:7/23/2008)... SEATTLE, July 23 /- Den... that it expects the Independent Data,Monitoring C...rim analysis,of overall survival relating to the C...e AdenoCarcinoma Treatment, also known as D9902B) ...ENGE is the Company,s investigational,active cellu...
Breaking Medicine Technology:Soyfoods Do Not Impact Sperm Count 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 1New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 2New Global Health Video Footage Available Rights Free on GlobalHealthReporting org 6281 3Nicotine addiction slashed in test of new cigarette smoking strategy 6279 1Nicotine addiction slashed in test of new cigarette smoking strategy 6279 2Nicotine addiction slashed in test of new cigarette smoking strategy 6279 3Anpath Group Inc Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority 28Metro 29 846 1Anpath Group Inc Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority 28Metro 29 846 2Anpath Group Inc Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority 28Metro 29 846 3Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 1209 1Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 1209 2Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 1209 3Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 1209 4
Blunt tipped forceps with small, slightly pointed grasping platforms on each tip. For general purpose (fine) membrane grasping and grasping membranes adherent to the retlnal surface.
Wash both 96- and 384-well plates and strips with the ELx50 Auto Strip Washer. As a self contained and programmable instrument, the ELx50 allows for full control of precise fluidic delivery from the
...raocular Electromagnet offers a truly unique surgi...r foreign bodies (IOFB). Other magnets are availab...s an intraocular electromagnet for use through a p...The D.O.R.C. Intraocular Electromagnet offers the ...
Philips SureSigns C1 compact, portable monitor features non-invasive measurement of essential vital signs as well as versatile spot check and continuous monitoring capabilities. The C1, ideal for tra
Medicine Products: